ab120265 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab120265 は 4 報の論文で使用されています。

  • Miwa H & Kondo T T-type calcium channel as a new therapeutic target for tremor. Cerebellum 10:563-9 (2011). PubMed: 21479969
  • Taylor JT  et al. Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 267:116-24 (2008). PubMed: 18455293
  • Li M  et al. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Cardiovasc Drug Rev 23:173-96 (2005). PubMed: 16007233
  • Huang L  et al. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309:193-9 (2004). PubMed: 14718587

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"